Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma (ARTIST)

AstraZeneca

Status: Completed

Conditions: Asthma

Treatments: Drug: Ciclesonide

Study type: Observational

Funder types: Industry

Identifiers

NCT00608218

Alves Artist 07/10

Details and patient eligibility

About

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.

Enrollment: 2,100 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Main inclusion criteria:

• History of persistent bronchial asthma

Main exclusion criteria:

• Hypersensitive to compounds of Alvesco
• Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)

Trial design

2,100 participants in 1 patient group

Artist

Treatment:

Drug: Ciclesonide